CBST

Cubist Pharmaceuticals, Inc. News Headlines

$60.86
*  
0.80
1.3%
Get CBST Alerts
*Delayed - data as of Jul. 31, 2014 14:59 ET  -  Find a broker to begin trading CBST now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CBST Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Cubist Misses Q2 Earnings Estimates on Weak Cubicin Sales - Analyst Blog
7/23/2014 1:10:00 PM - Zacks.com

Cubist Pharma. Q2 Profit Rises
7/22/2014 6:03:00 PM - RTT News

Cubist Pharmaceuticals Q2 14 Earnings Conference Call At 5:00 PM ET
7/22/2014 3:00:00 PM - RTT News

First Week of CBST September 20th Options Trading
7/22/2014 1:15:37 PM - BNK Invest

Zacks Rank #5 Additions for Tuesday - Tale of the Tape
7/22/2014 9:30:00 AM - Zacks.com

CBST Makes Notable Cross Below Critical Moving Average
6/27/2014 11:35:10 AM - BNK Invest

Cubist Pharma To Present At JMP Securities Conference; Webcast At 1:30 PM ET
6/25/2014 12:30:00 PM - RTT News

Cepheid Forms Pharma Alliance to Fight Antibiotic Resistance - Analyst Blog
6/23/2014 5:45:00 PM - Zacks.com

Cubist Gains FDA Approval for Sivextro - Analyst Blog
6/23/2014 11:50:00 AM - Zacks.com

Cubist Gets Priority Review from FDA for Antibiotic Candidate - Analyst Blog
6/20/2014 11:00:00 AM - Zacks.com

U.S. Hot Stocks: Hot Stocks to Watch
6/20/2014 9:05:00 AM - Dow Jones Business News

Must-know: Why Maverick Capital disposes position in Zoetis
6/16/2014 5:00:00 PM - Market Realist

Why Maverick Capital starts new position in Ctrip
6/16/2014 9:00:00 AM - Market Realist

Why Maverick opens new position in Cubist Pharmaceuticals
6/13/2014 5:00:00 PM - Market Realist

Why Maverick initiates new position in 21st Century Fox
6/13/2014 1:00:00 PM - Market Realist

Must-know: Why Maverick adds new position in Ashland
6/13/2014 9:00:00 AM - Market Realist

Why Maverick initiates new position in 21st Century Fox
6/12/2014 3:23:00 PM - Market Realist

Must-know: Lee Ainslie and Maverick Capital’s 1Q14 positions
6/12/2014 3:18:00 PM - Market Realist

Cubist Pharmaceuticals To Present At Goldman Sachs Conference;Webcast At 6:20PM
6/11/2014 3:00:00 PM - RTT News

Cubist Pharma's Antibiotics Portfolio Holds Promise - Analyst Blog
6/10/2014 4:30:00 PM - Zacks.com

Alnylam Up on Narrower-than-Expected Q1 Loss - Analyst Blog
5/12/2014 10:50:00 AM - Zacks.com

Cubist Announces Positive Results From Ph 3 Trials Of Ceftolozane/Tazobactam
5/9/2014 7:36:00 PM - RTT News

Should Basilea Pharmaceutica Be Trading At Twice This Price?
5/7/2014 2:12:00 PM - Seeking Alpha

CBST Makes Bullish Cross Above Critical Moving Average
4/29/2014 11:45:30 AM - BNK Invest

Huge Opportunities Are Now Possible Due To Market Inefficiencies In Valuing Antibiotic Companies Such As Cubist, Durata, And Cellceutix
4/25/2014 10:34:00 AM - Seeking Alpha